Beta
Adalimumab
medication Under reviewA TNF-inhibitor medication used to treat various autoimmune conditions like rheumatoid arthritis and Crohn's disease.
Research summary
Scientific evidence for adalimumab centers on its efficacy and safety in treating autoimmune diseases like rheumatoid arthritis, psoriasis, and Crohn's disease, with extensive data from clinical trials and long-term extensions showing sustained benefits in inflammation reduction. In healthy human subjects, research is limited primarily to pharmacokinetic, safety, and immunogenicity studies following single doses, which confirm good tolerability and predictable absorption, but no therapeutic benefits are established for this population. Overall consensus supports its use as a prescription biologic for specific inflammatory disorders, with ongoing monitoring for rare serious adverse events.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!